Ticker Details
Relmada Therapeutics, Inc.
IPO Date:	June 16, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$493.88M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 4.28%
Avg Daily Range (30 D):	$0.19 | 3.59%
Avg Daily Range (90 D):	$0.22 | 3.50%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	1.27M
Avg Daily Volume (90 D):	1.27M

Trade Size
Avg Trade Size (Sh.):	129
Avg Trade Size (Sh.) (30 D):	87
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	484
Avg Institutional Trade:	$2.11M
Avg Institutional Trade (30 D):	$.86M
Avg Institutional Trade (90 D):	$1.88M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.35M
Avg Closing Trade (30 D):	$.83M
Avg Closing Trade (90 D):	$2.44M
Avg Closing Volume:	206.8K

News

Jun 29, 2026 @ 11:00 AM Relmada Therapeutics Joins Russell 2000® and Ru... Source: Na

May 5, 2026 @ 11:00 AM Relmada Therapeutics to Present NDV-01 Abstracts a... Source: Na

Mar 12, 2026 @ 11:00 AM Relmada Therapeutics to Report Fourth Quarter 2025... Source: Na

Feb 26, 2026 @ 5:07 PM Psychedelic Medicine Advances: Here Are Five Compa... Source: Prnewswire

Jul 31, 2025 @ 11:00 AM Relmada Therapeutics to Report Second Quarter 2025... Source: Corporate Communications

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.11	$-.22	$-.29
Diluted EPS	$-.11	$-.22	$-.29
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-12.91M	$-19.05M	$-19.87M
Operating Income / Loss	$-15.01M	$-19.46M	$-20.33M
Cost of Revenue
Net Cash Flow	$1.56M	$6.28M	$2.11M
PE Ratio

Splits
Sep 30, 2019	1:4
Aug 12, 2015	1:5